Kazia Therapeutics (KZIA) Current Assets (2009 - 2025)
Kazia Therapeutics' (KZIA) quarterly Current Assets came in at $46.0 million in Q4 2025, up 1962.6% YoY from $2.2 million in Q4 2024, and up 1354.44% on a QoQ basis from $3.2 million in Q2 2025.
Kazia Therapeutics (KZIA) Current Assets (2009 - 2025) Analysis & Trends
Kazia Therapeutics (KZIA) has 17 years of Current Assets data on file, last reported at $46.0 million in Q4 2025.
- Quarterly Current Assets rose 1962.6% year-over-year to $46.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $46.0 million (up 1962.6% YoY) and the FY2025 annual result came in at $3.2 million, down 21.99% from the prior year.
- Current Assets rose to $46.0 million in Q4 2025, from $3.2 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $46.0 million in Q4 2025 to a low of $2.2 million in Q4 2024.
- A 5-year average of $11.3 million and a median of $6.0 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets sank 70.1% — and 2025, when it surged 1962.6%.
- Tracing KZIA's Current Assets over 5 years: stood at $12.2 million in 2021, then tumbled by 68.07% to $3.9 million in 2022, then surged by 34.12% to $5.2 million in 2023, then slumped by 57.27% to $2.2 million in 2024, then surged by 1962.6% to $46.0 million in 2025.
- The last three Current Assets figures came in at $46.0 million (Q4 2025), $3.2 million (Q2 2025), and $2.2 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | 45.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45.95 Mn |
| Jun 30, 2025 | 3.16 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Jun 30, 2024 | 4.05 Mn |
| Dec 31, 2023 | 5.21 Mn |
| Jun 30, 2023 | 7.20 Mn |
| Dec 31, 2022 | 3.89 Mn |
| Jun 30, 2022 | 6.77 Mn |
| Dec 31, 2021 | 12.17 Mn |
| Jun 30, 2021 | 22.63 Mn |
| Dec 31, 2020 | 15.04 Mn |
| Jun 30, 2020 | 6.98 Mn |
| Dec 31, 2019 | 5.16 Mn |
| Jun 30, 2019 | 5.26 Mn |
| Dec 31, 2018 | 6.32 Mn |
| Jun 30, 2018 | 7.01 Mn |
| Jun 30, 2017 | 14.63 Mn |
| Dec 31, 2016 | 11.07 Mn |
| Jun 30, 2016 | 14.55 Mn |
| Dec 31, 2015 | 32.13 Mn |